Clinical Trial Update: Trial of Low-intensity Anticoagulation to Reduce GI or Other Bleeding Complications With Equivalent Therapeutic Efficacy in HeartMate 3 LVAD Patients [Phase 4]

View source ↗

Summary

This clinical trial entry describes a Phase 4 study evaluating low-intensity anticoagulation to reduce gastrointestinal and other bleeding events while preservi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Asan Medical Center | Conditions: Advanced Heart Failure, Left Ventricular Assist Devices | Phase 4 | Status: NOT_YET_RECRUITING